Prescription opioid abuse and dependence among physicians: Hypotheses and treatment

Harvard Review of Psychiatry

Volumn 16, Issue 3, 2008, Pages 181-194

  Merlo, Lisa J ^a   Gold, Mark S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Addiction; Assessment; History; Opioids; Physician impairment; Prescription misuse; Secondhand exposure; Substance use disorders; Treatment

Indexed keywords

ACAMPROSATE; ANALGESIC AGENT; ANESTHETIC AGENT; BUPRENORPHINE; DISULFIRAM; METHADONE; NALTREXONE; OPIATE;

ALCOHOLISM; COGNITIVE THERAPY; DRUG ABUSE; DRUG DETOXIFICATION; HEALTH PROGRAM; HUMAN; OPIATE ADDICTION; PHYSICAL DISEASE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW;

ANALGESICS, OPIOID; ANESTHETICS; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; HUMANS; OPIOID-RELATED DISORDERS; PHYSICIAN IMPAIRMENT; PRESCRIPTIONS, DRUG; TREATMENT OUTCOME;

EID: 45849132027     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1080/10673220802160316     Document Type: Review

References (176)

1. Torre DM,Wang NY, Meoni LA, Young JH, Klag MJ, Ford DE. Suicide compared to other causes of mortality in physicians. Suicide Life Threat Behav 2005;35:146-53.
2. Ullman D, Phillips RL, Beeson L, et al. Cause-specific mortality among physicians with differing life-styles. JAMA 1991;265:2352-9.
3. Sankoff JS, Hockenberry S, Simon LJ, Jones RL. Mortality of young physicians in the United States, 1980-1988. Acad Med 1995;70:242-4.
4. Frank E, Biola H, Burnett CA. Mortality rates and causes among US physicians. Am J Prev Med 2000;19:155-9.
5. Wells KB, Lewis CE, Leake B, Ware JE. Do physicians preach what they practice? JAMA 1984;252:2846-8.
6. Gault R, Yeater RS, Ullrich IH. West Virginia physicians: cardiovascular risk factors, lifestyle and prescribing habits. W V Med J 1994;90:364-6.
7. Frank E, Schelbert KB, Elon L. Exercise counseling and personal habits of US women physicians. J Am Med Womens Assoc 2003;58:178-84.
8. Frank E, Brogan DJ, Mokdad AH, et al. Health behaviors of women physicians vs other women in the United States. Arch Intern Med 1998;158:342-8.
9. John U, Hanke M. Tobacco smoking prevalence among physicians and nurses in countries with different tobacco-control activities. Eur J Cancer Prev 2003;12:235-7.
10. Cigarette smoking among adults-United States, 2004. MMWR Morb Mortal Wkly Rep 2005;54:1121-4.
11. Weinger MB, Ancoli-Israel S. Sleep deprivation and clinical performance. JAMA 2002;287:955-7.
12. Defoe DM, Power ML, Holzman GB, Carpentieri A, Schulkin J. Long hours and little sleep: work schedules of residents in obstetrics and gynecology. Obstet Gynecol 2001;97:1015-8.
13. Williamson AM, Feyer AM. Moderate sleep deprivation produces impairments in cognitive and motor performance equivalent to legally prescribed levels of alcohol intoxication. Occup Environ Med 2000;57:649-55.
14. Gautam M, MacDonald R. Helping physicians cope with their own chronic illnesses. West J Med 2001;175:336-8.
15. McKevitt C, Morgan M, Dundas R, Holland WW. Sickness absence and 'working through' illness: comparison of two professional groups. J Public Health Med 1997;19:295-300.
16. Talbott G, Wright C. Chemical dependency in healthcare professionals. Occup Med 1987;2:581-91.
17. McAuliffe WE, Rohman M, Breer P, Wyshak G, Santangelo S, Magnuson E. Alcohol use and abuse in random samples of physicians and medical students. Am J Public Health 1991;81:177-82.
18. Krakowski A. Stress and the practice of medicine: physicians compared with lawyers. Psychother Psychosom 1984;42:143-51.
19. O'Connor PG, Spickard A. Physician impairment by substance abuse. Med Clin North Am 1997;81:1037-52.
20. Hughes PH, Brandenburg N, Baldwin DC, et al. Prevalence of substance use among US physicians. JAMA 1992;267:2333-9.
21. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007;297:249-51.
22. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Phys 2007;10:399-424.
23. SAMHSA. The NSDUH Report: patterns and trends in nonmedical prescription pain reliever use: 2002-2005. Rockville, MD: Office of Applied Studies, 2007.
24. Baldisseri MR. Impaired healthcare professional. Crit Care Med 2007;35:S106-16.
25. Farber NJ, Gilibert SG, Aboff BM, Collier VU,Weiner J, Boyer EG. Physicians' willingness to report impaired colleagues. Soc Sci Med 2005;61:1772-5.
26. Magnavita N. Management of impaired physicians in Europe. Med Lav 2006;97:762-73.
27. Dhai A, Szabo CP, McQuoid-Mason DJ. The impaired practitioner: scope of the problem and ethical challenges. S Afr Med J 2006;96:1069-72.
28. Graham C. Poland wrestles with the problem of drunken doctors. Lancet 2006;368:190-1.
29. Taub S. Physician health and wellness. Occup Med 2006;56:77-82.
30. Shanafelt TD, Sloan JA, Habermann TM. The well-being of physicians. Am J Med 2003;114:513-9.
31. Firth-Cozens J, Greenhalgh J. Doctors' perceptions of the links between stress and lowered clinical care. Soc Sci Med 1997;44:1017-22.
32. Shanafelt TD, Bradley KA, Wipf JE, Back AL. Burnout and self-reported patient care in an internal medicine residency program. Ann Intern Med 2002;136:358-67.
33. American Medical Association Database PF. H-95.955 Substance abuse among physicians. At http://www.ama-assn.org/apps/pf new/pf online/
34. American Medical Association Council on Mental Health. The sick physician: impairment by psychiatric disorders, including alcoholism and drug dependence. JAMA 1973;223:684-7.
35. Harris S. Alcoholism and drug addiction among physicians of Alabama. Transcripts Med Assoc Ala 1914:685-91.
36. Paget J. What becomes of medical students? St Bartholomew's Hosp Rep 1869;5:238-42.
37. Wenstone R. Nitrous oxide. Anaesthesia 1998;53:611.
38. Adams AK. The delayed arrival: from Davy (1800) to Morton (1846). J R Soc Med 1996;89:96P-100P.
39. Smith GB, Hirsch NP. Gardner Quincy Colton: pioneer physician in anesthesia. Anesth Analg 1991;72:382-91.
40. Defalque RJ, Wright AJ. The short, tragic life of Robert M. Glover. Anaesthesia 2004;59:394-400.
41. Hammonds WD, Steinhaus JE. Crawford W. Long: pioneer physician in anesthesia. J Clin Anesth 1993;5:163-7.
42. Kavanagh MF. The origin of the word "anesthesia." Calif West Med 1928;29:10-2.
43. Calatayud J, Gonzalez A. History of the development and evolution of local anesthesia since the coca leaf. Anesthesiology 2003;98:1503-8.
44. Pilcher JE. Ann Surg 1886;3:51-66.
45. Gold MS, Byars JA, Frost-Pineda K. Occupational exposure and addictions for physicians: case studies and theoretical implications. Psychiatr Clin North Am 2004;27:745-53.
46. Keys TE. Historical vignettes: Dr. Horace Wells (1815-1848). Anesth Analg 1972;51:684.
47. Warner SL. Sigmund Freud and money. JAmAcad Psychoanal 1989;17:609-22.
48. Mandel ID. Colk Koller: mankind's greatest benefactor? The story of local anesthesia. J Dent Res 1998;77:535-8.
49. Markel H. The accidental addict.NEngl J Med 2005;10:966-8.
50. Kenna GA, Wood MD. Alcohol use by healthcare professionals. Drug Alcohol Depend 2004;75:107-16.
51. Hughes PH, Storr C, Baldwin DC Jr, Williams KM, Conard S, Sheehan D. Patterns of substance use in the medical profession. Md Med J 1992;41:311-4.
52. Gallegos KV, Browne CH, Veit FW, Talbott GD. Addiction in anesthesiologists: drug access and patterns of substance abuse. QRB Qual Rev Bull 1988;14:116-22.
53. Gold MS, Melker RJ, Dennis DM, et al. Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis. J Addict Dis 2006;25:15-21.
54. Follette JW, Farley WJ. Anesthesiologist addicted to propofol. Anesthesiology 1992;77:817-8.
55. Iwersen-Bergmann S, Rosner P, Kuhnau HC, Junge M, Schmoldt A. Death after excessive propofol abuse. Int J Legal Med 2001;114:248-51.
56. Pomm RM, Harmon L. Evaluation and posttreatment of the impaired physician. Psychiatr Ann 2004;34:786-9.
57. Nace EP, Davis C, Hunter J. A comparison of male and female physicians treated for substance use and psychiatric disorders. Am J Addict 1995;4:156-62.
58. Schernhammer E, Colditz GA. Suicide rates among physicians: a quantitative and gender assessment (meta-analysis). Am J Psychiatry 2004;161:2295-302.
59. Roy A. Suicide in doctors. Psychiatr Clin North Am 1985;8:377-87.
60. Simon W. Suicide among physicians: prevention and postvention. Crisis 1986;7:1-13.
61. Schernhammer E. Taking their own lives: the high rate of physician suicide. N Engl J Med 2005;352:2473-6.
62. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology 2000;93:922-30.
63. Lew EA. Mortality experience among anesthesiologists, 1954-1976. Anesthesiology 1979;51:195-9.
64. Collins GB, McAllister MS, Jensen M, Gooden TA. Chemical dependency treatment outcomes of residents in anesthesiology: results of a survey. Anesth Analg 2005;101:1457-62.
65. Talbott G, Gallegos KV, Wilson PO, Porter T. The Medical Association of Georgia's impaired physician's program: review of the first 1000 physicians - analysis of specialty. JAMA 1987;257:2927-30.
66. Gallegos KV, Lubin BH, Bowers C, et al. Relapse and recovery: five to ten year follow-up study of chemically-dependent physicians. The Georgia experience. Md Med J 1992;41:315-9.
67. McAuliffe PF, Gold MS, Bajpai L, et al. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses 2006;66:874-82.
68. Menk EJ, Baumgarten RK, Kingsley CP, Culling RD, Middaugh R. Success of reentry into anesthesiology training programs by residents with a history of substance abuse. JAMA 1990;263:3060-2.
69. Lutsky I, Hopwood M, Abram SE, Cerletty JM, Hoffman RG, Kampine JP. Use of psychoactive substances in three medical specialties: anaesthesia, medicine, and surgery. Can J Anaesth 1994;41:561-7.
70. Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005;293:1453-60.
71. Fletcher CE, Ronis DL. Satisfaction of impaired health care professionals with mandatory treatment and monitoring. J Addict Dis 2005;24:61-75.
72. Storr CL, Trinkoff A, Hughes PH. Similarities of substance use between medical and nursing specialties. Subst Use Misuse 2000;35:1443-69.
73. Mensch B, Kanel D. Do job conditions influence the use of drugs? J Soc Behav 1988;29:169-84.
74. Bissell L, Jones RW. The alcoholic physician: a survey. Am J Psychiatry 1976;133:1142-6.
75. Boisaubin EV, Levine RE. Identifying and assisting the impaired physician. Am J Med Sci 2001;322:31-6.
76. Baldwin DC, Hughes PH, Conrad SE, et al. Substance abuse among senior medical students: a survey of 23 medical schools. JAMA 1991;265:2074-8.
77. Conrad SE, Hughes PH, Baldwin DC, et al. Substance use by fourth-year students at 13 U.S. medical schools. J Med Educ 1988;63:747-58.
78. Flaherty JA, Richman JA. Substance use and addiction among medical students, residents, and physicians. Psychiatr Clin North Am 1993;16:189-97.
79. McAuliffe W, Rohman M, Fishman P, et al. Psychoactive drug use by young and future physicians. J Health Soc Behav 1984;25:34-54.
80. Mansky P. Issues in the recovery of physicians from addictive illnesses. Psychiatr Q 1999;70:107-22.
81. Reimer C, Jurkat H, Maeculen B, Stetter F. Quality of life and health behavior of physicians with and without substance abuse. Psychotherapeut 2001;46:376-85.
82. Richman JA. Occupational stress, psychological vulnerability, and alcohol-related problems over time in future physicians. Alcohol Clin Exper Res 1992;16:166-71.
83. Frank E, Brogan DJ, Schiffman M. Prevalence and correlates of harassment among US women physicians. Arch Intern Med 1998;158:352-8.
84. Jex SM, Hughes PH, Storr CL, et al. Relations among stressors, strains, and substance use among resident physicians. Int J Addict 1992;27:979-94.
85. Kleber HD. The impaired physician: changes from the traditional view. J Subst Abuse Treat 1984;1:137-40.
86. Lloyd G. One hundred alcoholic doctors: a 21-year follow-up. Alcohol Alcohol 2002;37:370-4.
87. Hughes PH, Storr CL, Brandenburg N, Baldwin DC, Anthony JC, SheehanDV. Physician substance use by medical specialty. J Addict Dis 1999;18:23-37.
88. Bennet J, O'Donovan D. Substance misuse by doctors, nurses and other healthcare workers. Curr Opin Psychiatry 2001;14:195-9.
89. Zacny JP, Galinkin JL. Psychotropic drugs used in anesthesia practice: abuse liability and epidemiology of abuse. Anesthesiology 1999;90:269-88.
90. Verghese A. Physicians and addiction. N Engl J Med 2002;346:1510-1.
91. Baird WL, Morgan M. Substance misuse amongst anaesthesiologists. Anaesthesia 2000;55:943-5.
92. Christie J, Rosen I, Bellini L, et al. Presciption drug use and self-prescription among resident physicians. JAMA 1998;280:1253-5.
93. Chambers R, Belcher J. Self-reported health care over the past 10 years: a survey of general practitioners. Br J Gen Pract 1992;42:153-6.
94. Hughes PH, Conrad SE, Baldwin DC, et al. Resident physician substance abuse in the United States. JAMA 1991;265:2069-73.
95. Bailey CP, Smith FL, Kelly E, Dewey WL, Henderson G. How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance? Trends Pharmacol Sci 2006;27:558-65.
96. Zhang X, Bao L, Guan J. Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 2006;27:324-9.
97. Bell DM, McDonough JP, Ellison JS, Fitzhugh EC. Controlled drug misuse by Certified Registered Nurse Anesthetists. AANA J 1999;67:133-40.
98. Merlo LJ, Goldberger BA, Kolodner D, Fitzgerald K, Gold MS. Fentanyl and propofol exposure in the operating room: sensitization hypotheses and further data. 2007. On file with authors.
99. Takita A, Masui K, Kazama T. On-line monitoring of end-tidal propofol concentration in anesthetized patients. Anesthesiol 2007;106:659-64.
100. Hornuss C, Praun S, Villinger J, et al. Real-time monitoring of propofol in expired air in humans undergoing total intravenous anesthesia. Anesthesiology 2007;106:665-74.
101. Rieder J, Keller C, Brimacombe J, et al. Monitoring pollution by proton-transfer-reaction mass spectrometry during paediatric anaesthesia with positive pressure ventilation via the laryngeal mask airway or uncuffed tracheal tube. Anaesthesia 2002;52:663-6.
102. Sumner G, Lirk P, Hoerauf K, et al. Sevoflurane in exhaled air of operating room personnel. Anesth Analg 2003;97:1070-3.
103. Kelly KL. The financial devastation of physician addiction. Physician's Money Dig 2007(July). http://www.pmdnet.com/article.cfm?ID=4773
104. Emshoff JG, Price AW. Prevention and intervention strategies with children of alcoholics. Pediatrics 1999;103:1112-21.
105. Breiner SJ. The impaired physician. J Med Educ 1979;54:673.
106. Vaillant GE, ClarkW, Cyrus C, et al. Prospective study of alcohol treatment. Eight-year follow-up. Am J Med 1983;75:455-63.
107. Reid WH. Evaluating and treating disabled or impaired colleagues. J Psychiatr Pract 2007;13:44-8.
108. Harms BA, et al. A 25-year single institution analysis of health, practice, and fate of general surgeons. Ann Surg 2005;242:520-6.
109. American Medical Association Council on Ethical and Judical Affairs. Reporting impaired, incompetent, or unethical colleagues. Chicago: American Medical Association, 1992.
110. Angres D, Busch K. The chemically-dependent physician: clinical and legal considerations. In: Miller RD, ed. Legal implications of hospital policies and procedures. San Francisco: Jossey Bass, 1989:21-32.
111. Ross S. Clinical pearl: identifying an impaired physician. Virtual Mentor 2003;5(12). http://virtualmentor.amaassn. org/2003/12/cprl1-0312.html
112. Roberts K, Specker S. The health professionals services program: an alternative for physicians with psychiatric disorders. Minn Med 1999;82:54-6.
113. Nace EP, Birkmayer F, Sullivan MA, et al. Socially sanctioned coercion mechanisms for addiction treatment. Am J Addict 2007;16:15-23.
114. Fowlie DG. Doctors' drinking and fitness to practice. Alcohol Alcohol 2005;40:483-4.
115. Monahan G. Drug use/misuse among health professionals. Subst Use Misuse 2003;38:1877-81.
116. Walzer RS. Impaired physicians: an overview and update of the legal issues. J Leg Med 1990;11:131-98.
117. American Society of Addiction Medicine patient placement criteria. Chevy Chase, MD: ASAM, 2000.
118. McGovern MP, Angres DH, Leon S. Differential therapeutics and the impaired physician: patient-treatment matching by specificity and intensity. J Addict Dis 1998;17:93-107.
119. Angres D, Delisi S, Alam D, White B. A programmatic approach to treating physicians with a dual diagnosis. Psychiatr Ann 2004;34:776-80.
120. Wettstein RM. Commentary: quality improvement and psychiatric fitness for duty evaluations of physicians. J Am Acad Psychiatry Law 2005;33:92-4.
121. Washton AM, Gold MS, Pottash AC. Naltrexone in addicted physicians and business executives. NIDA Res Monogr 1984;55:185-90.
122. Vinson S, Graham NA, Gold MS. Socioeconomic inequities often translate into health inequalities [Letter]. J Nat Med Assn 2006;98:816-7.
123. Harmon L, Pomm R. Evaluation, treatment, and monitoring of disruptive physician behavior. Psychiatr Ann 2004;34:770-4.
124. Putnam D, Williams RA, Weese D, et al. The effect of inpatient psychiatric hospitalization on weight gain in children and adolescents. Psychiatr Hosp 1990;21:119-23.
125. Hodgkins CC, Jacobs WS, Gold MS. Weight gain after adolescent drug addiction treatment and supervised abstinence. Psychiatr Ann 2003;33:112-7.
126. Hodgkins CC, Seraphine AE, Frost-Pineda K, Gold MS. Adolescent drug addiction treatment and weight gain. J Addict Dis 2004;23:55-65.
127. Krahn DD, Kurth C, Demitrack M, et al. The relationship of dieting severity and bulimic behaviors to alcohol and other drug use in young women. J Subst Abuse 1992;4:341-53.
128. Gosnell BA, Krahn DD, Yracheta JM, et al. The relationship between intravenous cocaine self-administration and avidity for saccharin. Pharmacol Biochem Behav 1998;60:229-36.
129. Gosnell BA, Krahn DD. Taste and diet preferences as predictors of drug self-administration. NIDA Res Monogr 1998;169:154-75.
130. Salmon P. Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Clin Psychol Rev 2001;21:33-61.
131. Van RhenenW, Blonk RWB, van der Klink JJL, van Dijk FJH, Schaufeli WB. The effect of a cognitive and a physical stress-reducing programme on psychological complaints. Int Arch Occup Environ Health 2005;78:139-48.
132. Martin CA, Talbott G. Women physicians in the Georgia Impaired Physicians Program. J Am Womens Med Assoc 1987;42:115-21.
133. McGovern MP, Angres DH, Uziel-Miller ND, Leon S. Female physicians and substance abuse: comparisons with male physicians presenting for assessment. J Subst Abuse Treat 1998;15:525-33.
134. McGovern MP, Angres DH, ShawM, Rawal P. Gender of physicians with substance use disorders: clinical characteristics, treatment utilization, and post-treatment functioning. Subst Use Misuse 2003;38:993-1001.
135. Angres D, McGovern MP, Shaw MF, Rawal P. Psychiatric comorbidity and physicians with substance use disorders: a comparison between the 1980s and 1990s. J Addict Dis 2003;22:79-87.
136. Wijesinghe CP, Dunne F. Substance use and other psychiatric disorders in impaired practitioners. Psychiatr Q 2001;72:181-9.
137. Enders LE, Mercier JM. Treating chemical dependency: the need for including the family. Int J Addict 1993;28:507-19.
138. Eells MA. Interventions with alcoholics and their families. Nurs Clin North Am 1986;21:493-504.
139. Skipper GE. Treating the chemically dependent health professional. J Addict Dis 1997;16:67-73.
140. Roback HB, Moore RF, Waterhouse GJ, Martin PR. Confidentiality dilemmas in group psychotherapy with substance-dependent physicians. Am J Psychiatry 1996;153:1250-60.
141. Galanter M, Talbott D, Gallegos K, Rubenstone E. Combined Alcoholics Anonymous and professional care for addicted physicians. Am J Psychiatry 1990;147:64-8.
142. Moos RH, Moos BS. Paths of entry in to Alcoholics Anonymous: consequences for participation and remission. Alcohol Clin Exp Res 2005;29:1858-68.
143. Bogenschutz MP, Tonigan JS, Miller WR. Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change. J Stud Alcohol 2006;67:562-7.
144. Zemore SE, Kaskutas LA. Helping, spirituality, and Alcoholics Anonymous in recovery. J Stud Alcohol 2004;65:383-91.
145. Pagano ME, Friend KB, Tonigan JS, Stout RL. Helping other alcoholics in Alcoholics Anonymous and drinking outcomes: findings from Project MATCH. J Stud Alcohol 2004;65:766-73.
146. Walsh DC, Hingson RW, Merrigan DM, et al. A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med 1991;325:775-82.
147. Crowley TJ. Doctors' drug abuse reduced during contingency-contracting treatment. Alcohol Drug Res 1986;6:299-307.
148. Anfang SA, Faulkner LR, Fromson JA, et al. The American Psychiatric Association's resource document on guidelines for fitness-for-duty evaluations on physicians. J Am Acad Psychiatry Law 2005;33:85-8.
149. Anfang SA, Wall BW. Psychiatric fitness-for-duty evaluations. Psychiatr Clin North Am 2006;29:675-93.
150. Meyer DJ, Price M. Forensic psychiatry assessments of behaviorally disruptive physicians. J Am Acad Psychiatry Law 2006;34:72-81.
151. Turnbull J, Cunnington J, Unsal A, Norman G, Ferguson B. Competence and cognitive difficulty in physicians: a follow-up study. Acad Med 2006;81:915-8.
152. Shaw MF, McGovern MP, Angres DH, Rawal P. Physicians and nurses with substance use disorders. J Advanced Nurs 2004;47:561-71.
153. Gold MS, Pomm R, Frost-Pineda K. Urine testing confirmed, 5-year outcomes of impaired physicians. Paper presented at meeting of World Psychiatric Association, Florence, Italy, November 2004.
154. Preston KL, Silverman K, Schuster CR, Cone EJ. Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. NIDA Res Monogr 1997;167:130-45.
155. Harrison LD, Martin SS, Enev T, Harrington D. Comparing drug testing and self-report drug use among youth and young adults in the general population [DHHS Publication No. SMA 07-4249, Methodology Series M-7]. Rockville, MD: SAMHSA Office of Applied Studies, 2007.
156. Huestis MA, Cone EJ. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol 1998;22:445-54.
157. Cone EJ, Sampson-Cone AH, Darwin WD, Huestis MA, Oyler JM. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J Anal Toxicol 2003;27:386-401.
158. Kintz P, Villain M, Dumestre V, Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forens Sci Int 2005;153:81-4.
159. Skipper GE, Weinmann W, Thierauf A, et al. Ethyl glucoronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcohol 2004;39:445-9.
160. Peace MR, Tarnai LD. Performance evaluation of three onsite adulterant detection devices for urine specimens. J Anal Toxicol 2002;26:464-70.
161. Valtier S, Cody JT. A procedure for the detection of Stealth adulterant in urine samples. Clin Lab Sci 2002;15:111-5.
162. Jacobs WS, Hall JD, Pomm R, et al. Prognostic factors for physician addiction outcomes at five years. Paper presented at annual medical-scientific meeting of the American Society of Addiction Medicine, Washington, DC, April 2004.
163. Frost-Pineda K, Gold MS, Pomm R, Jacobs WS, Repetto M. Randomized urine testing: a safe and effective intervention for drug addiction. Paper presented at annual meeting of American College of Clinical Pharmacology, Palm Harbor, FL, September 2003.
164. Jacobs WS, Repetto M, Vinson S, Pomm R, Gold MS. Random urine testing as an intervention for drug addiction. Psychiatr Ann 2004;34:781-4.
165. Shore J. The Oregon experience with impaired physicians on probation: an eight year follow-up. JAMA 1987;257:2931-4.
166. Corsino BV, Morrow DH, Wallace CJ. Quality improvement and substance abuse: rethinking impaired provider policies. Am J Med Qual 1996;11:94-9.
167. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support public's demand for quality case? J Subst Abuse Treat 2003;25:117-21.
168. Brownell KD, Marlatt GA, Lichtenstein E, Wilson GT. Understanding and preventing relapse. Am Psychol 1986;41:765-82.
169. Miller WR, Sanchez-Craig M. How to have a high success rate in treatment: advice for evaluators of alcoholism programs. Addiction 1996;91:779-85.
170. Volkow ND, Li TK. Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol Ther 2005;108:3-17.
171. Newbury-Birch D, Walshaw D, Kamali F. Drink and drugs: from medical students to doctors. Drug Alcohol Depend 2001;64:265-70.
172. Newbury-Birch D, White M, Kamali F. Factors influencing alcohol and illicit drug use amongst medical students. Drug Alcohol Depend 2000;59:125-30.
173. Flynn JR. Treating the impaired physician: the hospital's role. Hosp Prog 1980;61:44-7.
174. Mavroforou A, Giannoukas A, Michalodimitrakis E. Alcohol and drug abuse among doctors. Med Law 2006;25:611-25.
175. Gold MS, Aronson M. This issue: physician health and impairment. Psychiatr Ann 2004;34:736-41.
176. Ziegler PP. Monitoring impaired physicians: a tool for relapse prevention. Penn Med 1992;95:38-40.